Literature DB >> 12296989

Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers.

S C Tan1, B K Patel, S H D Jackson, C G Swift, A J Hutt.   

Abstract

1. The stereoselective metabolism and pharmacokinetics of the enantiomers of ibuprofen have been investigated following the oral administration of the racemic drug (400 mg) to 12 healthy volunteers.2. The stereochemical composition of the drug in serum, both total and unbound, and drug and metabolites, both free and conjugated, in urine were determined by a combination of the direct and indirect chromatographic procedures to enantiomeric analysis. 3. The oral clearance of (S)-ibuprofen was significantly greater than that of the R-enantiomer (74.5 +/- 18.1 versus 57.1 +/- 11.7 ml min(-1); p < 0.05) and the clearance of (R)-ibuprofen via inversion was ca two fold that via alternative pathways. 4. Some 74.0 +/- 9.6% of the dose was recovered in urine over 24 h as ibuprofen, 2-hydroxyibuprofen and carboxyibuprofen, both free and conjugated with glucuronic acid. Analysis of the stereochemical composition of the urinary excretion products indicated that 68% of the dose of (R)-ibuprofen had undergone chiral inversion. 5. Metabolism via glucuronidation and both routes of oxidation, showed enantio-selectivity for (S)-ibuprofen, the enantiomeric ratios (S/R) in partial metabolic clearance being 7.1, 4.8 and 3.4 for formation of ibuprofen glucuronide, 2-hydroxyibuprofen and carboxyibuprofen respectively.6. Modest stereoselectivity was observed in the formation of (2'R, 2R)- and (2'S, 2S)-carboxyibuprofen in comparison to the alternative diastereoisomers, the ratios in formation clearance being 1.6 and 1.2 respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12296989     DOI: 10.1080/00498250210142994

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  8 in total

1.  The effect of operational stressors on ibuprofen pharmacokinetics.

Authors:  Cathy Boscarino; Andrea N Edginton; Henry Peng; K Wayne Riggs; András Szeitz; Bob Cheung
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

2.  Drugs of environmental concern modify Solea senegalensis physiology and biochemistry in a temperature-dependent manner.

Authors:  A González-Mira; I Varó; M Solé; A Torreblanca
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-03       Impact factor: 4.223

Review 3.  Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety.

Authors:  Nicholas Moore
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

4.  Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.

Authors:  Aleksi Tornio; Mikko Niemi; Pertti J Neuvonen; Janne T Backman
Journal:  Eur J Clin Pharmacol       Date:  2007-02-27       Impact factor: 2.953

Review 5.  Pharmacokinetics of Ibuprofen in children with cystic fibrosis.

Authors:  Emily E Han; Paul M Beringer; Stan G Louie; Mark A Gill; Bertrand J Shapiro
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers.

Authors:  Chaonan Zheng; Haiping Hao; Guangji Wang; Guowei Sang; Jianguo Sun; Peng Li; Jing Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jan-Mar       Impact factor: 2.441

7.  Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers.

Authors:  Soo Choon Tan; Bhavesh K Patel; Stephen H D Jackson; Cameron G Swift; Andrew J Hutt
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

8.  Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.

Authors:  Jessica Karlsson; Christopher J Fowler
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.